Geographic and Product Data

3 Months Ended

Mar. 29, 2013

Segment Reporting [Abstract]

Segment Reporting Disclosure [Text Block]

Note 9 — Geographic and Product Data

The Company markets and sells its products in over 60 countries and has manufacturing sites in the United States, Switzerland and Japan. Other than the United States, Japan, Korea, China, and Spain the Company does not conduct business in any country in which its sales exceed 5% of consolidated sales. Sales are attributed to countries based on location of customers. The composition of the Company’s net sales to unaffiliated customers is set forth below (in thousands):

	Three Months Ended
	March 29, 2013		March 30, 2012
United States	$	3,240	$	3,174
Japan		4,739		3,857
Korea		2,035		1,903
China		2,071		2,106
Spain		1,291		510
Other		4,625		3,959
Total	$	18,001	$	15,509

100% of the Company’s sales are generated from the ophthalmic surgical product segment and therefore the Company operates as one operating segment for financial reporting purposes. The Company’s principal products are implantable Collamer lenses (“ICLs”) used in refractive surgery and intraocular lenses (“IOLs”) used in cataract surgery. The composition of the Company’s net sales by product line is as follows (in thousands):

	Three Months Ended
	March 29, 2013		March 30, 2012
ICLs	$	10,631	$	8,605
IOLs		6,347		6,358
Core products		16,978		14,963
Other Surgical Products		1,023		546
Total	$	18,001	$	15,509

The Company sells its products internationally, which subjects the Company to several potential risks, including fluctuating foreign currency exchange rates (to the extent the Company’s transactions are not in U.S. dollars), regulation of fund transfers by foreign governments, United States and foreign export and import duties and tariffs, and political instability.